Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Germany.
Department of Orthopedics and Trauma Surgery, University Hospital Heidelberg, Germany.
J Magn Reson Imaging. 2017 Nov;46(5):1433-1440. doi: 10.1002/jmri.25688. Epub 2017 Mar 6.
To assess the feasibility of gadoteric acid for delayed gadolinium-enhanced magnetic resonance imaging of cartilage (dGEMRIC) and to compare the dGEMRIC values obtained using gadoteric acid with those obtained by an equimolar dose of Gd-DTPA.
At 3T, dGEMRIC of the wrist was performed twice using a T -weighted 3D-volumetric interpolated breath-hold examination sequence in 16 healthy volunteers (10 women; mean age 26.0 years) using gadoteric acid first and Gd-DTPA 3 weeks later. In addition, 24 patients with knee pain were examined using gadoteric acid (n = 12; seven women; mean age 45.8 years) or Gd-DTPA (n = 12; four women; mean age 47.1 years). T values, the relative decrease in T , and the delta R1 were compared using t-tests. Interobserver agreement was assessed using the intraclass correlation (ICC) between two independent readers.
At the wrist, there was no significant difference in delta R1 values (0.34 ± 0.10/s, 95% confidence interval [0.30;0.38]/s for gadoteric acid and 0.32 ± 0.09 [0.29;0.35]/s for Gd-DTPA, P = 0.24) or the relative decrease in T (0.25 ± 0.06 [0.29;0.35] msec for gadoteric acid and 0.24 ± 0.05 [0.22;0.27] msec for Gd-DTPA, P = 0.35). High observer agreement was found at precontrast (ICC = 0.87, P < 0.001) and postcontrast (ICC = 0.89, P < 0.001). Similarly, at the knee, there was no significant difference in delta R1 (0.39 ± 0.18 [0.32;0.47]/s for gadoteric acid and 0.41 ± 0.09 [0.38;0.45]/s for Gd-DTPA, P = 0.59) or the relative decrease in T (0.30 ± 0.10 [0.26;0.34] msec for gadoteric acid and 0.33 ± 0.05 [0.30;0.35] msec for Gd-DTPA, P = 0.28). High ICCs of 0.96 (P < 0.01) were noted both at precontrast and postcontrast.
dGEMRIC using gadoteric acid is feasible and yields comparable values when compared with Gd-DTPA.
2 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2017;46:1433-1440.
评估钆特酸在软骨延迟钆增强磁共振成像(dGEMRIC)中的可行性,并比较使用钆特酸和等摩尔剂量的 Gd-DTPA 获得的 dGEMRIC 值。
在 3T 下,16 名健康志愿者(10 名女性;平均年龄 26.0 岁)使用 T1 加权 3D 容积内插屏气检查序列进行腕关节两次 dGEMRIC 检查,首先使用钆特酸,3 周后使用 Gd-DTPA。此外,24 名膝关节疼痛患者分别使用钆特酸(n=12;7 名女性;平均年龄 45.8 岁)或 Gd-DTPA(n=12;4 名女性;平均年龄 47.1 岁)进行检查。使用 t 检验比较 T 值、T 的相对降低和 delta R1。使用两位独立读者之间的组内相关系数(ICC)评估观察者间的一致性。
在腕关节,delta R1 值(0.34±0.10/s,95%置信区间[0.30;0.38]/s 为钆特酸和 0.32±0.09 [0.29;0.35]/s 为 Gd-DTPA,P=0.24)或 T 的相对降低(0.25±0.06 [0.29;0.35] msec 为钆特酸和 0.24±0.05 [0.22;0.27] msec 为 Gd-DTPA,P=0.35)均无显著差异。在预对比(ICC=0.87,P<0.001)和后对比(ICC=0.89,P<0.001)均有很高的观察者一致性。同样,在膝关节,delta R1(0.39±0.18 [0.32;0.47]/s 为钆特酸和 0.41±0.09 [0.38;0.45]/s 为 Gd-DTPA,P=0.59)或 T 的相对降低(0.30±0.10 [0.26;0.34] msec 为钆特酸和 0.33±0.05 [0.30;0.35] msec 为 Gd-DTPA,P=0.28)均无显著差异。在预对比和后对比时,ICC 均为 0.96(P<0.01),均有很高的一致性。
使用钆特酸进行 dGEMRIC 是可行的,并且与 Gd-DTPA 相比,结果具有可比性。
2 技术功效:第 2 阶段 J. 磁共振成像 2017;46:1433-1440.